BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Genesis MedTech and Silk Road Medical Partner to Treat Carotid Artery Disease in China

Since its establishment in 2019, Genesis MedTech Group has continuously strived to enhance its peripheral interventional portfolio, offering compre...

March 11, 2024 | News

Eisai Boosts Support for Alzheimer's Diagnosis with $15 Million Investment in C2N Diagnostics

Eisai Co., Ltd. announced a significant step forward in the fight against Alzheimer's disease (AD) today, with its U.S. subsidiary Eisai Inc. committing up...

March 07, 2024 | News

Epitomee® Submits Innovative Weight Loss Capsule for FDA Clearance

The Epitomee® capsule is designed for oral use and stands out as a drug-free option, clinically validated to be both effective and safe for adu...

March 07, 2024 | News

Phagenesis Secures $42M in Series D Funding to Revolutionize Swallowing Dysfunction Treatment

Phagenesis, a pioneering UK company which has developed a revolutionary neurostimulation system to treat swallowing dysfunction, has closed a $42M&nbs...

March 05, 2024 | News

Bridging Gaps, Building Futures: Ruth Kuguru’s Approach to Healthcare Solutions in APAC

In this insightful interview with BioPharma APAC, Ruth Kuguru, Executive Director of Communications & Engagement at Novartis for Asia Pacific, Middle E...

March 05, 2024 | Interaction

Huawei Introduces Solution for Smarter Healthcare through Medical Tech Digitalization

David Shi, Vice President of Huawei's ICT Marketing & Solution Sales, said, "To accelerate the intelligent upgrade of the healthcare industry, Huawei, ...

February 29, 2024 | News

TechInvention Lifecare Starts Building Advanced Global Health Solutions Center

GCMC has been acknowledged for its global significance at the 2nd World Local Production Forum in The Hague on 6-8 November 2023, organized by the ...

February 29, 2024 | News

Teva Partners with Jiangsu Nhwa to Enhance AUSTEDO® Access in China

“Nhwa has deep neuro-psychiatry expertise and capabilities, from research and development to commercialization,” commented Theodor Wee,...

February 28, 2024 | News

Sparsentan Receives CHMP Endorsement for IgA Nephropathy Treatment in Europe

CSL Vifor together with Travere Therapeutics, Inc., disclosed that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CH...

February 26, 2024 | News

BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a strategic partnership with Camtech Health, a ...

February 22, 2024 | News

Innovent's IBI311 Clears Phase 3 Hurdle for Thyroid Eye Disease with Promising Results

The trial also successfully met its key secondary endpoints, including the overall response rate, the percentage of subjects achieving a clinical activity ...

February 20, 2024 | News

Japan Accelerates Approval Process for Groundbreaking Urothelial Cancer Treatment by Astellas

Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") announced that Japan's Ministry of Health, Labour a...

February 19, 2024 | News

AffaMed's NDA for DEXTENZA Accepted by Singapore HSA for Post-Surgery Ocular Treatment

AffaMed Therapeutics ("AffaMed"), a biotechnology company dedicated to developing and commercializing transformative pharmaceutical, and surgical products&...

February 19, 2024 | News

Synbio Tech's Probiotic TWK10 Earns Taiwan FDA Approval for Anti-fatigue Health Claim

Synbio Tech is thrilled to announce that its groundbreaking probiotic strain, Lactiplantibacillus plantarum TWK10, has been awarded a prestigious...

February 19, 2024 | News

Stay Connected